Concepedia

Deepa Balasubramaniam

DB

8

Publications

870

Citations

8

H-Index

2003

Active since

Affiliations

Eli Lilly (United States)(Current)

University of North Carolina at Chapel Hill

The University of Texas at Austin

National Institute of Allergy and Infectious Diseases

New York University

Deepa Balasubramaniam is an author at Eli Lilly (United States) specializing in natural sciences, chromatography, and bioanalysis.

ORCID

Top concepts

Publications per year

2003–2024

8

Publications

8

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 484 citations · Full text

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · 2020 · 173 citations · Full text

Tobacco protein separation by aqueous two-phase extraction

Deepa Balasubramaniam, C. A. Wilkinson, Kevin Van Cott et al. · Journal of Chromatography A · 2003 · 99 citations

, , +9

An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif

Deepa Balasubramaniam, Oliver C. Schroeder, Anna M. Russell et al. · Journal of Lipid Research · 2022 · 46 citations · Full text

Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics

Karen Froning, Jack B. Maguire, Arlene Sereno et al. · Nature Communications · 2020 · 35 citations · Full text

Rows per page

1–5 of 8